We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Voice-Activated Sample Pre-Treatment Device Enables Hands-Free, Safer DNA Handling

By LabMedica International staff writers
Posted on 10 Feb 2023

Scientists using samples containing pathogens work with the smallest amounts possible in order to avoid accidental infection. More...

In the case of highly contagious bacterial diseases, on-site sample analysis is suitable for rapid diagnoses. Additionally, scientists with visual or other physical impairments can find it difficult to operate complex instruments, particularly those designed for tiny volumes. Now, the same technology used by smart voice assistants could also make the laboratory a safer place for scientists and technicians handling infectious samples.

Hands-free devices that can be operated quickly using voice commands could make the laboratory safer for scientists and technicians. Researchers at Kyung Hee University (Yongin, South Korea) set out to combine a speech recognition app with a miniaturized extraction system to do just that. The researchers first built a microfluidic chip with multiple chambers linked together by six 3-way solenoid valves, which were operated by a micro-controller connected to a Bluetooth module. The palm-sized device weighed only 11 ounces and was powered by a portable battery or a 5V smartphone charger. Using existing speech recognition software, the team went on to customize a smartphone app to listen for specific voice commands.

The voice-activated system is simple to operate. As soon as the user says one of the operation commands out loud, the app wirelessly sends an initiation signal to the micro-controller. After receiving the signal, the micro-controller automatically begins a series of steps, including sample loading, washing and releasing the purified DNA into a collection chamber. Currently, the system requires the user to touch the smartphone to start the speech recognition software, although the entire operation could soon become completely hands-free with the addition of virtual assistant software.

The researchers conducted tests of the system in which the voice-controlled device extracted DNA from Salmonella Typhimurium, purifying a 10-µL sample with an efficiency of 70% in less than a minute. The system’s performance was lower as compared to a traditional DNA extraction kit, although its voice control, portability and quick automation lend it an advantage for convenient and safe bacterial DNA testing, according to the researchers.

Related Links:
Kyung Hee University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.